Formulated Topical Methylene Blue (0.5 mg/mL)

DRUG2 trials

Sponsors

Daryoush Hamidi Alamdari, PhD

Conditions

Advanced Basal Cell Carcinoma (BCC)Infiltrative Basal Cell CarcinomaInoperable DiseaseMorpheaform Basal Cell CarcinomaNoduloulcerative Basal Cell CarcinomaSCC - Squamous Cell CarcinomaSCC - Squamous Cell Carcinoma of Skin

Phase 3

Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue

Enrolling by invitationNCT07311070

Daryoush Hamidi Alamdari, PhDAdvanced Basal Cell Carcinoma (BCC), Infiltrative Basal Cell Carcinoma, Inoperable Disease +2

Start: 2025-10-21End: 2026-01-20Target: 20Updated: 2026-01-06

Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy

Enrolling by invitationNCT07311057

Daryoush Hamidi Alamdari, PhDInoperable Disease, SCC - Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma of Skin

Start: 2025-12-20End: 2026-01-20Target: 20Updated: 2026-01-06